Street Talk

Pharmaxis raising $9.2 million via Morgans

Anthony Macdonald, Yolanda Redrup and Kanika Sood

Nov 15, 2021 – 1.08pm

Subscribe to gift this article

Gift 5 articles to anyone you choose each month when you subscribe.

Already a subscriber?

Clinical stage drug development company Pharmaxis is tapping investors to raise $9.2 million on Monday, with the capital set to support the next phase of clinical trials for its cancer and scar treatment candidates.

Its anti-cancer drug PXS-5505 has clinical trials underway in liver cancer and bone marrow cancer, and hopes to extend this to other cancers including pancreatic and brain cancer in the future.

Anthony Macdonald is a Chanticleer columnist. He is a former Street Talk co-editor and has 10 years' experience as a business journalist and worked at PwC, auditing and advising financial services companies.

Yolanda Redrup is the editor of the AFR Rich List. She previously reported on technology, healthcare and Street Talk.

Kanika Sood is a journalist based in Sydney who writes for the Street Talk column.